Abstract:Osteoarthritis (OA) is a degenerative joint condition that contributes to years lived with disability. Current therapeutic approaches are limited as there are no disease-modifying interventions able to delay or inhibit the progression of disease. In recent years there has been an increasing interest in the immunomodulatory and regenerative properties of mesenchymal stem/stromal cells (MSCs) to develop new OA therapies. Extracellular vesicles (EVs) mediate many of the biological effects of these cells and may represent an alternative avoiding the limitations of cell-based therapy. There is also a growing interest in EV modifications to enhance their efficacy and applications. Recent preclinical studies have provided strong evidence supporting the potential of MSC EVs for the development of OA treatments. Thus, MSC EVs may regulate chondrocyte functions to avoid cartilage destruction, inhibit abnormal subchondral bone metabolism and synovial tissue alterations, and control pain behavior. EV actions may be mediated by the transfer of their cargo to target cells, with an important role for proteins and non-coding RNAs modulating signaling pathways relevant for OA progression. Nevertheless, additional investigations are needed concerning EV optimization, and standardization of preparation procedures. More research is also required for a better knowledge of possible effects on different OA phenotypes, pharmacokinetics, mechanism of action, long-term effects and safety profile. Furthermore, MSC EVs have a high potential as vehicles for drug delivery or as adjuvant therapy to potentiate or complement the effects of other approaches.

The potential therapeutic role of extracellular vesicles in osteoarthritis

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration

The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation.

The Role of Extracellular Vesicles in the Pathogenesis, Diagnosis, and Treatment of Osteoarthritis.

MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis

Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis

Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management

Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis

Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis

Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis

Immunomodulation of MSCs and MSC-Derived Extracellular Vesicles in Osteoarthritis

The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review

Mesenchymal stem cell-derived extracellular vesicles, osteoimmunology and orthopedic diseases

Strategies for Cartilage Repair in Osteoarthritis Based on Diverse Mesenchymal Stem Cells‐Derived Extracellular Vesicles

Extracellular vesicles in osteoarthritis of peripheral joint and temporomandibular joint

Extracellular vesicles: Potential role in osteoarthritis regenerative medicine

A Novel Extracellular Vesicles Production System Harnessing Matrix Homeostasis and Macrophage Reprogramming Mitigates Osteoarthritis

Mesenchymal stem cell-derived extracellular vesicles: a regulator and carrier for targeting bone-related diseases

Mesenchymal stem cell-derived extracellular vesicles in joint diseases: Therapeutic effects and underlying mechanisms